Newman N - Search Results

1

Phase I trial of recombinant interleukin-2 and recombinant beta-interferon in refractory neoplastic diseases.

Paolozzi F, Zamkoff K, Doyle M, Konrad M, Bradley EC, Rudolph A, Newman N, Gullo J, Scalzo A, Poiesz B. Paolozzi F, et al. Among authors: newman n. J Biol Response Mod. 1989 Apr;8(2):122-39. J Biol Response Mod. 1989. PMID: 2786553

2

Phase I trial of tallysomycin S10b, a bleomycin analogue.

Paolozzi FP, Gaver RC, Newman NB, Poiesz BJ, DeFino S, Louie A, Comis RL. Paolozzi FP, et al. Among authors: newman nb. Invest New Drugs. 1990 May;8(2):171-80. doi: 10.1007/BF00177253. Invest New Drugs. 1990. PMID: 1696567

3

A phase I trial of subcutaneously administered recombination tumor necrosis factor to patients with advanced malignancy.

Zamkoff KW, Newman NB, Rudolph AR, Young J, Poiesz BJ. Zamkoff KW, et al. Among authors: newman nb. J Biol Response Mod. 1989 Oct;8(5):539-52. J Biol Response Mod. 1989. PMID: 2795095

4

Phase II trial of iproplatin (CHIP) in previously untreated patients with colorectal cancer.

Blitzer JB, Newman N, Ginsberg SJ, Louie A, Scalzo A, Poiesz B. Blitzer JB, et al. Among authors: newman n. Am J Clin Oncol. 1988 Dec;11(6):650-1. doi: 10.1097/00000421-198812000-00012. Am J Clin Oncol. 1988. PMID: 3189231

5

Phase II study of iproplatin (CHIP) in previously treated small-cell lung cancer.

Granfortuna JM, Newman N, Ginsberg SJ, Louie A, Comis RL, Gullo JJ, Poiesz BJ. Granfortuna JM, et al. Among authors: newman n. Am J Clin Oncol. 1989 Aug;12(4):355-7. doi: 10.1097/00000421-198908000-00016. Am J Clin Oncol. 1989. PMID: 2547306

6

A phase II trial of iproplatin (CHIP) in previously treated advanced breast cancer.

Meisner DJ, Ginsberg S, Ditch A, Louie A, Newman N, Comis R, Poiesz B. Meisner DJ, et al. Among authors: newman n. Am J Clin Oncol. 1989 Apr;12(2):129-31. doi: 10.1097/00000421-198904000-00008. Am J Clin Oncol. 1989. PMID: 2705402

7

Phase I--preliminary phase II trial of iproplatin, a cisplatin analogue.

Paolozzi FP, Gaver R, Poiesz BJ, Louie A, DiFino S, Comis RL, Newman N, Ginsberg S. Paolozzi FP, et al. Among authors: newman n. Invest New Drugs. 1988 Sep;6(3):199-206. doi: 10.1007/BF00175398. Invest New Drugs. 1988. PMID: 3192385

8

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.

Graziano SL, Mazid R, Newman N, Tatum A, Oler A, Mortimer JA, Gullo JJ, DiFino SM, Scalzo AJ. Graziano SL, et al. Among authors: newman n. J Clin Oncol. 1989 Oct;7(10):1398-406. doi: 10.1200/JCO.1989.7.10.1398. J Clin Oncol. 1989. PMID: 2550590

9

Prognostic significance of K-ras codon 12 mutations in patients with resected stage I and II non-small-cell lung cancer.

Graziano SL, Gamble GP, Newman NB, Abbott LZ, Rooney M, Mookherjee S, Lamb ML, Kohman LJ, Poiesz BJ. Graziano SL, et al. Among authors: newman nb. J Clin Oncol. 1999 Feb;17(2):668-75. doi: 10.1200/JCO.1999.17.2.668. J Clin Oncol. 1999. PMID: 10080613

10

Phase I study of gemcitabine and carboplatin in advanced non-small cell lung carcinoma.

Gajra A, Mehdi SA, Kirshner J, Newman N, Graziano SL. Gajra A, et al. Among authors: newman n. Lung Cancer. 2001 May;32(2):189-96. doi: 10.1016/s0169-5002(00)00213-0. Lung Cancer. 2001. PMID: 11325490 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,034 results

Search Page

Filters